Lupus miliaris disseminatum faciei in a patient with systemic lupus erythematosus and Sjögren’s syndrome

We herein report a rare case of lupus miliaris disseminatus faciei on the chin and neck in a patient with systemic lupus erythematosus and Sjögren’s syndrome. Histopathological features showed focal aggregates of epithelioid granulomas accompanied by mononuclear cell infiltration in the upper dermis. Immunohistological examination showed enhanced expression of CD68 and CD163. Recent findings have implicated a key role of innate immunity in the pathogenesis of systemic lupus erythematosus, and alteration in M1 and M2 macrophage profile has been suggested. Increased expression of CD163 in the affected skin and other organs, and elevated serum levels of soluble CD163, are reported in systemic lupus erythematosus. Our results may suggest that activated M2 macrophages participated in the induction of lupus miliaris disseminatus faciei in a patient with systemic lupus erythematosus and Sjögren’s syndrome.

[1]  Qingrui Yang,et al.  The contribution of macrophages to systemic lupus erythematosus. , 2019, Clinical immunology.

[2]  H. Yamanaka,et al.  Usefulness of soluble CD163 as a biomarker for macrophage activation syndrome associated with systemic lupus erythematosus , 2019, Lupus.

[3]  Adam C. Labonte,et al.  Identification of alterations in macrophage activation associated with disease activity in systemic lupus erythematosus , 2018, PloS one.

[4]  S. Sethi,et al.  Granulomatous Rosacea Versus Lupus Miliaris Disseminatus Faciei—2 Faces of Facial Granulomatous Disorder: A Clinicohistological and Molecular Study , 2018, The American Journal of dermatopathology.

[5]  N. Kambe,et al.  Palisaded neutrophilic and granulomatous dermatitis associated with systemic lupus erythematosus: possible involvement of CD163+ M2 macrophages in two cases, and a review of published works , 2018, Lupus.

[6]  W. Parks,et al.  Macrophages, Wound Healing, and Fibrosis: Recent Insights , 2018, Current Rheumatology Reports.

[7]  R. King,et al.  Extrafacial nuchal lupus miliaris disseminatus faciei , 2017, JAAD case reports.

[8]  L. Y. McGirt,et al.  Extrafacial lupus miliaris disseminatus , 2016, JAAD case reports.

[9]  L. Distel,et al.  CD163+ M2c-like macrophages predominate in renal biopsies from patients with lupus nephritis , 2016, Arthritis Research & Therapy.

[10]  W. Kim,et al.  Lupus Miliaris Disseminatus Faciei With Isolated Axillary Involvement , 2016, Journal of cutaneous medicine and surgery.

[11]  Jinhua Xu,et al.  Macrophage Polarization Modulates Development of Systemic Lupus Erythematosus , 2015, Cellular Physiology and Biochemistry.

[12]  Y. Inoue,et al.  CD163 expression is increased in the involved skin and sera of patients with systemic lupus erythematosus. , 2012, European journal of dermatology : EJD.

[13]  N. Al‐Mutairi.  Nosology and therapeutic options for lupus miliaris disseminatus faciei , 2011, The Journal of dermatology.

[14]  G. Plewig,et al.  Lupus miliaris disseminatus faciei evoked during pregnancy in a patient with cutaneous lupus erythematosus , 1998, International journal of dermatology.

[15]  H. Zaher,et al.  LUPUS MILIARIS DISSEMINATUS FACIEI‐PATHOLOGIC STUDY OE EARLY, FULLY DEVELOPED, AND LATE LESIONS , 1993, International journal of dermatology.